Figure 2.
Overview of 2 subtypes of perinephric myxoid pseudotumor of fat (PMPF). Significant differences between the 2 subtypes of patients in terms of the size of the largest mass and underlying renal disease. Among the ‘overt’ type, there are different imaging manifestations between the native kidney and the allograft PMPF. This classification method may guide the selection of treatment regimens.
